ARCHIVES

Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors

This article is from The Cancer Letter archive.

Vol. 40 No. 41 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Recompetition of $1.9 Mil. Primate Contract Approved

November 15, 1985

NCI Programs: Institute Seeks White Papers On Technology

September 11, 1998

Gallo Actively Searching For New Position

July 1, 1994

Liver Transplants Extend Survival In Early-Stage Cancer

January 27, 2006

ACS Plans To Review Prostate Cancer Screening Guideline

March 20, 2009

Baltimore Reports On New Method To Aid Leukemia Therapy Design

May 20, 1977